• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome.腹泻期间早期容量扩张及随后溶血尿毒综合征期间的相对肾保护作用。
Arch Pediatr Adolesc Med. 2011 Oct;165(10):884-9. doi: 10.1001/archpediatrics.2011.152. Epub 2011 Jul 22.
2
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用:与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
3
Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.儿童感染产志贺样毒素大肠杆菌 O157:H7 后溶血尿毒综合征的危险因素:多变量分析。
Clin Infect Dis. 2012 Jul;55(1):33-41. doi: 10.1093/cid/cis299. Epub 2012 Mar 19.
4
Clinical characteristics of children with hemolytic uremic syndrome in Hangzhou, China.中国杭州溶血尿毒综合征患儿的临床特征
World J Pediatr. 2017 Apr;13(2):183-185. doi: 10.1007/s12519-017-0021-x. Epub 2017 Mar 28.
5
[Capacity of the oligoanuric period in the prediction of renal sequelae in patients with postdiarrheal hemolytic uremic syndrome].[少尿期对腹泻后溶血尿毒综合征患者肾脏后遗症的预测能力]
Arch Argent Pediatr. 2012 May-Jun;110(3):221-6. doi: 10.5546/aap.2012.221.
6
Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.挪威儿童溶血尿毒综合征的临床特征、治疗干预及长期情况:一项1999年至2008年的全国性回顾性研究
BMC Infect Dis. 2016 Jun 13;16:285. doi: 10.1186/s12879-016-1627-7.
7
Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.预测产志贺毒素大肠杆菌感染儿童的溶血尿毒综合征及肾脏替代治疗
Clin Infect Dis. 2020 Apr 10;70(8):1643-1651. doi: 10.1093/cid/ciz432.
8
Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.基于人群的队列研究显示,腹泻相关性溶血尿毒综合征的长期预后与 1 年随访时的肾脏损伤标志物相关性差。
Pediatr Nephrol. 2019 Apr;34(4):657-662. doi: 10.1007/s00467-018-4131-z. Epub 2018 Oct 27.
9
Timing and utility of ultrasound in diarrhea-associated hemolytic uremic syndrome: 7-year experience of a large tertiary care hospital.超声检查在腹泻相关溶血尿毒综合征中的时机选择与应用:一家大型三级医疗中心的7年经验
Clin Pediatr (Phila). 2010 May;49(5):418-21. doi: 10.1177/0009922809342582. Epub 2010 Jan 13.
10
Fluid restriction versus volume expansion in children with diarrhea-associated HUS: a retrospective observational study.腹泻相关性 HUS 患儿的液体限制与容量扩张:一项回顾性观察研究。
Pediatr Nephrol. 2021 Jan;36(1):103-109. doi: 10.1007/s00467-020-04673-6. Epub 2020 Jul 17.

引用本文的文献

1
Bloody diarrhea, STEC infection, and HUS in the molecular microbiology era.分子微生物学时代的血性腹泻、产志贺毒素大肠杆菌感染与溶血尿毒综合征
Pediatr Nephrol. 2025 Aug 23. doi: 10.1007/s00467-025-06930-y.
2
How We Interpret Thrombosis with Thrombocytopenia Syndrome?我们如何解读血栓性血小板减少性紫癜?
Int J Mol Sci. 2024 May 1;25(9):4956. doi: 10.3390/ijms25094956.
3
Volume expansion mitigates Shiga toxin-producing E. coli-hemolytic uremic syndrome in children.容量扩充可减轻儿童产志贺样毒素大肠埃希菌溶血尿毒综合征。
Pediatr Nephrol. 2024 Jun;39(6):1901-1907. doi: 10.1007/s00467-023-06276-3. Epub 2024 Jan 19.
4
Shiga toxin-producing Escherichia coli O157:H7 among diarrheic patients and their cattle in Amhara National Regional State, Ethiopia.埃塞俄比亚阿姆哈拉州腹泻患者及其牛中的产志贺毒素大肠杆菌 O157:H7。
PLoS One. 2023 Dec 21;18(12):e0295266. doi: 10.1371/journal.pone.0295266. eCollection 2023.
5
Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: A prospective cohort study.儿童溶血尿毒综合征:英格兰、威尔士、北爱尔兰和爱尔兰的前瞻性队列研究。
Epidemiol Infect. 2023 Sep 1;151:e160. doi: 10.1017/S0950268823001413.
6
Duration of prodromal phase and severity of hemolytic uremic syndrome.前驱期持续时间和溶血尿毒综合征的严重程度。
Pediatr Nephrol. 2024 Jan;39(1):213-219. doi: 10.1007/s00467-023-06104-8. Epub 2023 Aug 1.
7
Distinguishing Clinical and Research Risks in Pragmatic Clinical Trials: The Need for Further Stakeholder Engagement.区分实用临床试验中的临床风险与研究风险:进一步让利益相关者参与的必要性。
Am J Bioeth. 2023 Aug;23(8):39-42. doi: 10.1080/15265161.2023.2217146.
8
Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).超水化治疗改善产志贺毒素大肠埃希菌感染儿童的肾脏结局:一项多国嵌入式簇交叉随机试验(HIKO STEC 试验)。
Trials. 2023 May 27;24(1):359. doi: 10.1186/s13063-023-07379-w.
9
Factors affecting dialysis duration in children with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome.产志贺毒素大肠杆菌相关性溶血尿毒综合征患儿透析时间的影响因素。
Pediatr Nephrol. 2023 Aug;38(8):2753-2761. doi: 10.1007/s00467-022-05839-0. Epub 2023 Jan 27.
10
Diagnosis and Treatment for Shiga Toxin-Producing Associated Hemolytic Uremic Syndrome.产志贺样毒素大肠埃希菌相关性溶血尿毒综合征的诊断与治疗。
Toxins (Basel). 2022 Dec 23;15(1):10. doi: 10.3390/toxins15010010.

本文引用的文献

1
Acute kidney injury: can we improve prognosis?急性肾损伤:我们能否改善预后?
Pediatr Nephrol. 2010 Dec;25(12):2401-12. doi: 10.1007/s00467-010-1508-z. Epub 2010 Apr 9.
2
Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories.临床实验室对产志贺毒素大肠杆菌感染的诊断建议。
MMWR Recomm Rep. 2009 Oct 16;58(RR-12):1-14.
3
Acute bloody diarrhea: a medical emergency for patients of all ages.急性血性腹泻:各年龄段患者的医疗急症。
Gastroenterology. 2009 May;136(6):1887-98. doi: 10.1053/j.gastro.2009.02.059. Epub 2009 May 7.
4
Shiga-toxin producing Escherichia coli and the hemolytic uremic syndrome: what have we learned in the past 25 years?产志贺毒素大肠杆菌与溶血尿毒综合征:过去25年我们了解到了什么?
Adv Exp Med Biol. 2009;634:1-17. doi: 10.1007/978-0-387-79838-7_1.
5
Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.少尿和无尿持续时间作为腹泻后溶血尿毒综合征慢性肾脏相关后遗症的预测指标
Pediatr Nephrol. 2008 Aug;23(8):1303-8. doi: 10.1007/s00467-008-0799-9. Epub 2008 May 9.
6
Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key.预防产志贺毒素大肠杆菌O157感染的家庭传播:及时隔离兄弟姐妹可能是关键。
Clin Infect Dis. 2008 Apr 15;46(8):1189-96. doi: 10.1086/587670.
7
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用:与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
8
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.产志贺毒素大肠杆菌与溶血尿毒综合征
Lancet. 2005;365(9464):1073-86. doi: 10.1016/S0140-6736(05)71144-2.
9
Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.腹泻相关性溶血尿毒综合征的长期肾脏预后:一项系统评价、荟萃分析和元回归分析
JAMA. 2003 Sep 10;290(10):1360-70. doi: 10.1001/jama.290.10.1360.
10
Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study.腹泻儿童中产志贺毒素大肠杆菌:一项前瞻性即时检测研究。
J Pediatr. 2002 Aug;141(2):172-7. doi: 10.1067/mpd.2002.125908.

腹泻期间早期容量扩张及随后溶血尿毒综合征期间的相对肾保护作用。

Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome.

作者信息

Hickey Christina A, Beattie T James, Cowieson Jennifer, Miyashita Yosuke, Strife C Frederic, Frem Juliana C, Peterson Johann M, Butani Lavjay, Jones Deborah P, Havens Peter L, Patel Hiren P, Wong Craig S, Andreoli Sharon P, Rothbaum Robert J, Beck Anne M, Tarr Phillip I

机构信息

Division of Gastroenterology and Nutrition, Department of Pediatrics, Washington University School of Medicine, 1 Children's Place, St Louis, MO 63110, USA.

出版信息

Arch Pediatr Adolesc Med. 2011 Oct;165(10):884-9. doi: 10.1001/archpediatrics.2011.152. Epub 2011 Jul 22.

DOI:10.1001/archpediatrics.2011.152
PMID:21784993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4064458/
Abstract

OBJECTIVES

To determine if interventions during the pre-hemolytic uremic syndrome (HUS) diarrhea phase are associated with maintenance of urine output during HUS.

DESIGN

Prospective observational cohort study.

SETTINGS

Eleven pediatric hospitals in the United States and Scotland.

PARTICIPANTS

Children younger than 18 years with diarrhea-associated HUS (hematocrit level <30% with smear evidence of intravascular erythrocyte destruction), thrombocytopenia (platelet count <150 × 10³/mm³), and impaired renal function (serum creatinine concentration > upper limit of reference range for age).

INTERVENTIONS

Intravenous fluid was given within the first 4 days of the onset of diarrhea.

OUTCOME MEASURE

Presence or absence of oligoanuria (urine output ≤ 0.5 mL/kg/h for >1 day).

RESULTS

The overall oligoanuric rate of the 50 participants was 68%, but was 84% among those who received no intravenous fluids in the first 4 days of illness. The relative risk of oligoanuria when fluids were not given in this interval was 1.6 (95% confidence interval, 1.1-2.4; P = .02). Children with oligoanuric HUS were given less total intravenous fluid (r = -0.32; P = .02) and sodium (r = -0.27; P = .05) in the first 4 days of illness than those without oligoanuria. In multivariable analysis, the most significant covariate was volume infused, but volume and sodium strongly covaried.

CONCLUSIONS

Intravenous volume expansion is an underused intervention that could decrease the frequency of oligoanuric renal failure in patients at risk of HUS.

摘要

目的

确定在溶血尿毒综合征(HUS)腹泻期进行干预是否与HUS期间尿量维持有关。

设计

前瞻性观察队列研究。

地点

美国和苏格兰的11家儿科医院。

参与者

18岁以下患有腹泻相关性HUS(血细胞比容水平<30%且血涂片有血管内红细胞破坏证据)、血小板减少(血小板计数<150×10³/mm³)和肾功能受损(血清肌酐浓度>年龄参考范围上限)的儿童。

干预措施

在腹泻发作的前4天内给予静脉输液。

观察指标

少尿或无少尿(尿量≤0.5 mL/kg/h超过1天)的情况。

结果

50名参与者的总体少尿率为68%,但在疾病发作的前4天未接受静脉输液的参与者中,少尿率为84%。在此期间未给予输液时少尿的相对风险为1.6(95%置信区间,1.1 - 2.4;P = 0.02)。与无少尿的儿童相比,少尿性HUS儿童在疾病发作的前4天接受的总静脉输液量(r = -0.32;P = 0.02)和钠量(r = -0.27;P = 0.05)更少。在多变量分析中,最显著的协变量是输注量,但量和钠密切相关。

结论

静脉补液扩容是一种未得到充分利用的干预措施,可降低有HUS风险患者少尿性肾衰竭的发生率。